drugIndia
Cart
Glimestar-PM1 Tablet ER

Glimestar-PM1 Tablet ER

Glimepiride (1mg) + Pioglitazone (15mg) + Metformin (500mg)

Mankind Pharma Ltd
Hypertension
82.41103.0120% OFF
In Stock
1
Safe & Secure
Easy Returns
24/7 Support
Delivery
drugIndia verified
Save 71%
Best Alternative100% Match

Glyzee PM1 Tablet ER

Zeelab Pharmacy Pvt Ltd

Pioglitazone 15mg
Glyzee PM1 Tablet ER

Pack Size

1 units

Price

24.0020% off
Glyzee PM1 Tablet ER is 100% same as Glimestar-PM1 Tablet ER
Better ValueSame QualitySame Effectiveness

Save ₹58

that's 71% off!

composition
  1. Pioglitazone 15mg
  2. Glimepiride 1mg
  3. Metformin 500mg
Buy Now
82.4120% OFF
103.01

About This Medicine

Product description & overview

Glimestar-PM1 Tablet ER: Comprehensive Diabetes Management

Glimestar-PM1 is a once-daily extended-release tablet formulation designed for managing type 2 diabetes mellitus. Combining three key medications – glimepiride (1mg), metformin (500mg), and pioglitazone (15mg) – this unique formula offers comprehensive blood sugar control.

Glimepiride stimulates insulin release from the pancreas, improving glucose uptake by muscle cells. Metformin lowers blood glucose levels through multiple mechanisms like reducing hepatic glucose production and enhancing insulin sensitivity. Pioglitazone, a thiazolidinedione derivative, promotes glucose uptake in peripheral tissues, further contributing to blood sugar control.

Glimestar-PM1 delivers precise doses of these medications for efficient and sustained glycemic management. This formulation ensures consistent efficacy throughout the day, promoting patient compliance and convenient dosing.

Important: Consult with a healthcare professional before starting any new medication regimen. This product is not suitable for all individuals and may interact with certain drugs or conditions.

Active composition

Glimepiride 1 mg

+2 more active ingredients

About Glimepiride

Glimepiride is an oral hypoglycemic agent used to manage blood sugar levels in patients with type 2 diabetes mellitus. It works by stimulating the pancreas to release more insulin, thereby lowering blood glucose levels and preventing the symptoms associated with diabetes. Glimepiride is often prescribed alongside diet and exercise to enhance glycemic control and reduce the risk of diabetes-related complications, such as kidney damage and neuropathy. In summary, Glimepiride is an essential medication for controlling blood sugar levels in type 2 diabetes patients.

How It Works

Glimepiride stimulates insulin secretion from pancreatic beta cells and enhances insulin sensitivity in peripheral tissues, facilitating glucose uptake and lowering blood sugar levels.

Medicine Strength
1 mg

All Active Ingredients

Glimepiride1 mg
Pioglitazone15 mg
Metformin500 mg

Pioglitazone

Pioglitazone activates peroxisome proliferator-activated receptor gamma (PPAR-γ), enhancing insulin sensitivity and glucose metabolism.

Metformin

Metformin reduces hepatic glucose production and enhances peripheral insulin sensitivity, lowering blood glucose levels.

Dosage & How to Use

Dosage information not available. Please consult your doctor or pharmacist.

Safety Advice

Important precautions

Side Effect Occurrence

Based on clinical trials and patient reports.

Overall Tolerance

Most patients tolerate well

Only 2.3% reported effects

Common Side Effects

Headache8%
Nausea5%
Dizziness3%
Fatigue2%
Rash1%
Higher
Lower

Safety Advice

Alcohol

It is unsafe to consume alcohol with Glimestar-PM1 Tablet ER.

High Risk

Pregnancy

Glimestar-PM1 Tablet ER may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.

Medical Advice

Driving

Your ability to drive may be affected if your blood sugar is too low or too high. Do not drive if these symptoms occur.

Exercise Caution

Liver

Glimestar-PM1 Tablet ER should be used with caution in patients with liver disease. Dose adjustment of Glimestar-PM1 Tablet ER may be needed. Please consult your doctor. Use of Glimestar-PM1 Tablet ER is not recommended in patients with severe liver disease.

Regular Checkup

Breastfeeding

Glimestar-PM1 Tablet ER is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.

Consult Doctor

Kidney

Glimestar-PM1 Tablet ER should be used with caution in patients with kidney disease. Dose adjustment of Glimestar-PM1 Tablet ER may be needed. Please consult your doctor. Use of Glimestar-PM1 Tablet ER is, however, not recommended in patients with severe kidney disease. Regular monitoring of kidney function test is advisable while you are taking this medicine.

Regular Checkup

Customer Reviews

0 reviews for Glimestar-PM1 Tablet ER

Products matching your search